"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs

International Journal of Pharmaceutics

Volumn 487, Issue 1-2, 2015, Pages 197-204

  Martinelli, Francesco ^a   Balducci, Anna Giulia ^a   Rossi, Alessandra ^a   Sonvico, Fabio ^a   Colombo, Paolo ^a   Buttini, Francesca ^a,b  

^a UNIVERSITY OF PARMA   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Capsule motion; Dry powder inhaler; Formoterol fumarate; HandiHaler; RS01; Spray dried insulin; Turbospin

Indexed keywords

FORMOTEROL FUMARATE; INSULIN; LACTOSE; AEROSOL; DRUG CARRIER; MICROCAPSULE; POWDER;

AEROSOL; ARTICLE; DISPERSION; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRY POWDER; DRY POWDER INHALER; HYPOBARISM; INHALATION; PRIORITY JOURNAL; EQUIPMENT DESIGN; MEDICINAL CHEMISTRY; MICROCAPSULE; POWDER;

AEROSOLS; CAPSULES; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRY POWDER INHALERS; EQUIPMENT DESIGN; FORMOTEROL FUMARATE; INSULIN; POWDERS;

EID: 84927945098     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.04.003     Document Type: Article

References (20)

1. W.P. Adams, S.L. Lee, R. Plourde, R.A. Lionberger, C.M. Bertha, W.H. Doub, J.-M. Bovet, and A.J. Hickey Effects of device and formulation on in vitro performance of dry powder inhalers AAPS J. 14 2012 400 409 10.1208/s12248-012-9352-7
2. R.P. Aquino, L. Prota, G. Auriemma, T. Santoro a Mencherini, G. Colombo, and P. Russo Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells Int. J. Pharm. 426 2012 100 107 10.1016/j.ijpharm.2012.01.026
3. A.G. Balducci, S. Cagnani, F. Sonvico, A. Rossi, P. Barata, G. Colombo, P. Colombo, and F. Buttini Pure insulin highly respirable powders for inhalation Eur. J. Pharm. Sci. 51 2014 110 117 10.1016/j.ejps.2013.08.009
4. S.R.B. Behara, P. Kippax, I. Larson, D.A.V. Morton, and P. Stewart Kinetics of emitted mass - a study with three dry powder inhaler devices Chem. Eng Sci. 66 2011 5284 5292 10.1016/j.ces.2011.07.029
5. S.R.B. Behara, I. Larson, P. Kippax, D.A.V. Morton, and P. Stewart The kinetics of cohesive powder de-agglomeration from three inhaler devices Int. J. Pharm. 421 2011 72 81 10.1016/j.ijpharm.2011.09.024
6. F. Buttini, P. Colombo, M.P.E. Wenger, P. Mesquida, C. Marriott, and S.A. Jones Back to basics: the development of a simple, homogenous, two-component dry-powder inhaler formulation for the delivery of budesonide using miscible vinyl polymers J. Pharm. Sci. 97 2008 1257 1267 10.1002/jps.21126
7. F. Buttini, E. Cuoghi, M. Miozzi, A. Rossi, F. Sonvico, and P. Colombo Insulin spray-dried powder and smoothed lactose: a new formulation strategy for nasal and pulmonary delivery R.N. Dalby, P.R. Byron, J. Peart, J.D. Suman, S.J. Farr, P.M. Young, Respir. Drug Deliv. 3 2012 835 840 Book 3: 1-933722-59-2
8. F. Buttini, M. Miozzi, A.G. Balducci, P.G. Royall, G. Brambilla, P. Colombo, R. Bettini, and B. Forbes Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers Int. J. Pharm. 465 2014 42 51 10.1016/j.ijpharm.2014.01.033
9. N.Y.K. Chew, H. Chan, D.F. Bagster, and J. Mukhraiya Characterization of pharmaceutical powder inhalers: estimation of energy input for powder dispersion and effect of capsule device configuration J. Aerosol Sci. 33 2002 999 1008
10. M.S. Coates, H.-K. Chan, D.F. Fletcher, and H. Chiou Influence of mouthpiece geometry on the aerosol delivery performance of a dry powder inhaler Pharm. Res. 24 2007 1450 1456 10.1007/s11095-007-9262-z
11. M.S. Coates, D.F. Fletcher, H.-K. Chan, and J.A. Raper Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1: grid structure and mouthpiece length J. Pharm. Sci. 93 2004 2863 2876 10.1002/jps.20201
12. M.S. Coates, D.F. Fletcher, H.-K. Chan, and J.A. Raper The role of capsule on the performance of a dry powder inhaler using computational and experimental analyses Pharm. Res. 22 2005 923 932 10.1007/s11095-005-4587-y
13. M.J. Donovan, S.H. Kim, V. Raman, and H.D. Smyth Dry powder inhaler device influence on carrier particle performance J. Pharm. Sci. 101 2012 1097 1107 10.1002/jps.22824
14. D.E. Geller, J. Weers, and S. Heuerding Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere™ technology J. Aerosol Med. Pulm. Drug Deliv. 24 2011 175 182 10.1089/jamp.2010.0855
15. N. Grekas, K. Athanassiou, K. Papataxiarchou, S. Rizea Savu, and L. Silvestro Pharmacokinetic study for the establishment of bioequivalence of two inhalation treatments containing budesonide plus formoterol J. Pharm. Pharmacol. 66 2014 1677 1685 10.1111/jphp.12303
16. A.M. Healy, M.I. Amaro, K.J. Paluch, and L. Tajber Dry powders for oral inhalation free of lactose carrier particles Adv. Drug Deliv. Rev. 75 2014 32 52 10.1016/j.addr.2014.04.005
17. N. Islam, and M.J. Cleary Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery - a review for multidisciplinary researchers Med. Eng. Phys. 34 2012 409 427 10.1016/j.medengphy.2011.12.025
18. A. Schuster, C. Haliburn, G. Doring, and M.H. Goldman Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study for the Freedom Study Group Thorax 68 2013 344 350 10.1136/thoraxjnl-2012-202059
19. J. Shur, S. Lee, W. Adams, R. Lionberger, J. Tibbatts, and R. Price Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers AAPS J. 14 2012 667 676 10.1208/s12248-012-9379-9
20. Y.J. Son, P.W. Longest, G. Tian, and M. Hindle Evaluation and modification of commercial dry powder inhalers for the aerosolization of a submicrometer excipient enhanced growth (EEG) formulation Eur. J. Pharm. Sci. 49 2013 390 399 10.1016/j.ejps.2013.04.011